Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rabeprazole - EA Pharma

Drug Profile

Rabeprazole - EA Pharma

Alternative Names: Aciphex; AcipHex Sprinkle; E-3810 - Eisai; LY-307640; Pariet; Pariprazole; Pariprazole sodium; Rabecure Pack 400; Rabecure Pack 800; Rabefine; Rabeloc; Rabeprazole sodium; Rablet

Latest Information Update: 07 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eisai Co Ltd
  • Developer EA Pharma; Eisai Co Ltd
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiulcers; Gastric antisecretories; Small molecules
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Duodenal ulcer; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis; Zollinger-Ellison syndrome
  • Discontinued Dyspepsia

Most Recent Events

  • 07 Aug 2018 Cerecor acquires Rabeprazole from Avadel Pharmaceuticals
  • 13 Feb 2018 Cerecor enters into purchase agreement with Avadel Pharmaceuticals to purchase and acquire all rights to rabeprazole
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Gastro-oesophageal-reflux(In neonates) in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top